CANSINO BIOLOGICS IN

6185

End-of-day quote - 10/27
165.6HKD	-2.87%

Prev.	170.5000
Open	171.8000
High	174.0000
Low	163.6000
Volume	1 050 965

7d ago	Mexico could share some COVID-19 vaccine liabilities with laboratories
7d ago	Mexico could absorb some COVID-19 vaccine liabilities
10/15	China's Sinopharm offers experimental COVID-19 vaccines to students - WSJ
10/13	Mexico Signs Agreements to Buy Potential Covid-19 Vaccines

	Short Term	Mid-Term	Long Term
Trend	Neutral	Neutral	Bullish
Resistance	190	271	271
Spread/Res.	-13%	-39%	-39%
Spread/Supp.	4,1%	16%	31%
Support	159	142	126

Sales 2020	275 M 40,9 M 40,9 M
Net income 2020	-6,87 M -1,02 M -1,02 M
Net cash 2020	2 901 M 432 M 432 M
P/E ratio 2020	-5 381x
Yield 2020	-

Capitalization	60 561 M 9 031 M 9 022 M
EV / Sales 2020	210x
EV / Sales 2021	89,4x
Nbr of Employees	429
Free-Float	37,1%

CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in...

>> Read more

Sector :

Biopharmaceuticals

Calendar :

No events available

Trading Rating :

Investor Rating :

Mean consensus	BUY
Number of Analysts	5
Average target price	157,99 CNY
Last Close Price	143,28 CNY
Spread / Highest target	51,7%
Spread / Average Target	10,3%
Spread / Lowest Target	-67,8%